Blood Products & Immunohematology Reference Laboratory

The Indian Health Service seeks blood products and immunohematology reference laboratory services via a combined synopsis/solicitation RFQ (IHS1527367), with quotations due September 16, 2026 at 4:00 PM CST via email. The procurement uses full and open competition with no set-aside, and is issued under FAR part 12 simplified procedures for commercial products and services.

Place of performance is Lawton Indian Hospital, Lawton, Oklahoma, with F.O.B. Destination. The Indian Health Service intends to establish a single firm-fixed-price Blanket Purchase Agreement for five years (September 30, 2026 through September 29, 2031) with a stipulated aggregate amount of $325,000 and individual call limitations of $150,000. NAICS code 621991 (Blood and Organ Banks) applies; size standard is $40.0 million.

Quoters must provide unit prices for a comprehensive range of blood products, supplies, and immunohematology testing services across six service sections: Blood Products & Components (13 line items); Compatibility & Transfusion Testing (5 line items); Antibody Detection & Identification (9 line items); Red Cell Antigen Typing/Phenotyping (15 line items); Molecular/Genotyping (2 line items); Fetal Hemoglobin (2 line items); and miscellaneous services including after-hours call-in, STAT pickup and delivery, and consultation. All prices are firm-fixed and inclusive of transportation, packaging, special transport containers, and delivery. Every line item must receive a unit price quotation; this is not a volume guarantee.

Critical performance requirements include 1-hour STAT response plus delivery time, 4-hour non-routine and 8-hour routine compatibility testing turnaround, 6-hour immunohematology reporting, and 24/7 telephone coverage with acceptance of verbal emergency orders. Evaluation prioritizes demonstrated ability to provide the complete range of products with minimal gaps, meet turnaround times, maintain sufficient inventory, and provide consultation services; non-price factors are weighted more heavily than price. Past performance will be evaluated based on relevant experience within three years. Prompt payment discounts will not be considered in evaluation.